The field of women’s hormone health is rapidly evolving as emerging research sheds light on the intricate complexities of hormonal fluctuations throughout the female lifespan. Striking and maintaining optimal endocrine balance throughout the reproductive years and menopausal transition remains a delicate objective at the forefront of functional anti-aging medicine.
However, ongoing scientific discoveries have spearheaded remarkable advances in evidence-based hormone therapies and bio-identical hormone replacement (BHRT) interventions designed to restore balance. Recent innovations in drug formulations, timing, delivery methods, and dosing protocols allow for increasingly personalized therapeutic strategies that not only effectively address cumbersome symptoms but also promote long-term well-being during perimenopause, menopause, and beyond.
“The best faculty, best providers, best patient outcomes. All based on science, experience, and care. “— Erika Schwartz, MD
As Erika Schwartz, MD, a global pioneer in disease prevention and hormone therapeutics, summarized in the quote above, the Everything About Hormone Health For Womenmasterclass was an incredible success. The February event gathered a group of forward-thinking health professionals who came to meet, learn from, and engage with acclaimed advanced endocrinology practitioners and educators.
Alongside a fun weekend in Boca Raton, FL, participants enjoyed three days of ground-breaking educational sessions led by top women’s health experts with invaluable expertise. Faculty members shared relevant and practical clinical insights for the modern practitioner committed to patient-centered care, making the experience empowering and informative.
Women’s health in the United States and across the world continues to worsen, with a widespread lack of access to healthcare and low awareness levels contributing to disparities in outcomes between men and women. Driving prevailing health inequity is a stark gap in medical research, which has been historically performed primarily on male subjects. Women have been excluded from clinical trials throughout history, limiting our understanding of female-specific health conditions and their overall health.
From cardiovascular risk factors to breast cancer and fertility, women’s health encompasses a wide range of complex issues that require specialized attention and research. Despite making up half of the global population, women are largely under-studied and underrepresented in medicine, which extends to the clinical setting. The statistics are telling: Women die at higher rates than men from heart attacks and strokes; they comprise 80 percent of all new cases of autoimmune diseases; and they are three times more likely to experience mental health disorders. The list goes on.